Amy Brodtmann
Affiliations: | University of Melbourne, Parkville, Victoria, Australia |
Area:
stroke recovery; functional neuroimagingGoogle:
"Amy Brodtmann"Mean distance: 16.5 (cluster 15) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Xiong Y, Khlif MS, Egorova-Brumley N, et al. (2023) Neural correlates of verbal fluency revealed by longitudinal T1, T2 and FLAIR imaging in stroke. Neuroimage. Clinical. 38: 103406 |
| Egorova-Brumley N, Dhollander T, Khan W, et al. (2023) Changes in White Matter Microstructure Over 3 Years in People With and Without Stroke. Neurology |
| Egorova-Brumley N, Liang C, Khlif MS, et al. (2022) White matter microstructure and verbal fluency. Brain Structure & Function |
| Salah Khlif M, Egorova-Brumley N, Bird LJ, et al. (2022) Cortical thinning 3 years after ischaemic stroke is associated with cognitive impairment and APOE ε4. Neuroimage. Clinical. 36: 103200 |
| Syeda W, Ermine CM, Khilf MS, et al. (2022) Long-term structural brain changes in adult rats after mild ischaemic stroke. Brain Communications. 4: fcac185 |
| Hung SH, Khlif MS, Kramer S, et al. (2022) Post-stroke White Matter Hyperintensities and Physical Activity: A CANVAS Study Exploratory Analysis. Medicine and Science in Sports and Exercise |
| Rost NS, Brodtmann A, Pase MP, et al. (2022) Post-Stroke Cognitive Impairment and Dementia. Circulation Research. 130: 1252-1271 |
| Egorova-Brumley N, Khlif MS, Werden E, et al. (2022) Grey and white matter atrophy 1 year after stroke aphasia. Brain Communications. 4: fcac061 |
| Hung SH, Kramer S, Werden E, et al. (2022) Pre-stroke Physical Activity and Cerebral Collateral Circulation in Ischemic Stroke: A Potential Therapeutic Relationship? Frontiers in Neurology. 13: 804187 |
| Bu N, Churilov L, Khlif MS, et al. (2022) Early Brain Volume Changes After Stroke: Subgroup Analysis From the AXIS-2 Trial. Frontiers in Neurology. 12: 747343 |